Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients

Journal of Neuro-Oncology

Volumn 125, Issue 2, 2015, Pages 307-315

  Wakefield, Amanda ^a,b   Pignata, Antonella ^a,b   Ghazi, Alexia ^a,b   Ashoori, Aidin ^a,b   Hegde, Meenakshi ^a,b   Landi, Daniel ^a,b   Gray, Tara ^a,b   Scheurer, Michael E ^b   Chintagumpala, Murali ^b   Adesina, Adekunle ^b   Gottschalk, Stephen ^a,b   Hicks, John ^b   Powell, Suzanne Z ^c   Ahmed, Nabil ^a,b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

CMV; GBM; Glioblastoma; IE1 72; Pediatric; pp65

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; NUCLEIC ACID; PROTEIN IE1 72; UNCLASSIFIED DRUG; VIRUS PROTEIN; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; IE1 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN; MATRIX PROTEIN; PHOSPHOPROTEIN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL DEATH; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; MALE; OVERALL SURVIVAL; PEDIATRICS; PHENOTYPE; PROGNOSIS; TUMOR GROWTH; VIRUS GENOME; BRAIN NEOPLASMS; GENETICS; METABOLISM; PATHOGENICITY; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOMEGALOVIRUS; FEMALE; GLIOBLASTOMA; HUMANS; IMMEDIATE-EARLY PROTEINS; INFANT; MALE; PHOSPHOPROTEINS; VIRAL MATRIX PROTEINS;

EID: 84945449982     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1905-z     Document Type: Article

References (22)

1. Suri V et al (2009) Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro-oncology 11:274–280
2. Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30:10–14
3. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114–123
4. Hatiboglu MA, Wei J, Wu AS, Heimberger AB (2010) Immune therapeutic targeting of glioma cancer stem cells. Target Oncol 5:217–227
5. Bollard CM et al (2004) Cytotoxic T lymphocyte therapy for Epstein–Barr virus + Hodgkin’s disease. J Exp Med 200:1623–1633
6. Ahmed N et al (2010) HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clini Cancer Res 16:474–485
7. Negro A, Brar BK, Lee KF (2004) Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog Horm Res 59:1–12
8. Liu G et al (2004) HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res 64:4980–4986
9. Ghazi A et al (2012) Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother 35:159–168
10. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116:79–86
11. Cobbs CS et al (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350
12. Mitchell DA et al (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 10:10–18
13. Cobbs CS (2011) Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae 2:10
14. Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C (2011) The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol 103:231–238
15. Forslund O et al (2014) Regarding human cytomegalovirus in neuroblastoma. Cancer Med 3(4):1038–1040
16. Baryawno et al (2011) Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Investig 121(10):4043–4055
17. Rahbar A et al (2013) Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol 57:36–42
18. Lokensgard JR et al (1999) Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J Hum Virol 2:91–101
19. Salvant BS, Fortunato EA, Spector DH (1998) Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 72:3729–3741
20. Ahmed N et al (2007) Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res 67:5957–5964
21. Prins RM, Cloughesy TF, Liau LM (2008) Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 5:539–541
22. Soderberg-Naucler C, Peredo I, Stragliotto G (2013) Valganciclovir in patients with glioblastoma. N Engl J Med 369:2066–2067